Owc Pharmaceutical Research Stock Beta
OWCP Stock | USD 0.0001 0.00 0.00% |
OWC Pharmaceutical Research fundamentals help investors to digest information that contributes to OWC Pharmaceutical's financial success or failures. It also enables traders to predict the movement of OWC Pink Sheet. The fundamental analysis module provides a way to measure OWC Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OWC Pharmaceutical pink sheet.
OWC |
OWC Pharmaceutical Research Company Beta Analysis
OWC Pharmaceutical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current OWC Pharmaceutical Beta | -224.47 |
Most of OWC Pharmaceutical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OWC Pharmaceutical Research is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, OWC Pharmaceutical Research has a Beta of -224.4707. This is 26201.24% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The beta for all United States stocks is notably higher than that of the company.
OWC Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OWC Pharmaceutical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of OWC Pharmaceutical could also be used in its relative valuation, which is a method of valuing OWC Pharmaceutical by comparing valuation metrics of similar companies.OWC Pharmaceutical is currently under evaluation in beta category among related companies.
As returns on the market increase, returns on owning OWC Pharmaceutical are expected to decrease by larger amounts. On the other hand, during market turmoil, OWC Pharmaceutical is expected to outperform it.
OWC Fundamentals
Return On Asset | -0.64 | |||
Current Valuation | 49.75 K | |||
Shares Outstanding | 497.5 M | |||
Shares Owned By Insiders | 11.15 % | |||
Price To Earning | (12.76) X | |||
Price To Book | 42.29 X | |||
EBITDA | (10.25 M) | |||
Net Income | (10.26 M) | |||
Cash And Equivalents | 1.47 M | |||
Cash Per Share | 0.01 X | |||
Debt To Equity | 0.15 % | |||
Current Ratio | 3.12 X | |||
Book Value Per Share | (0.02) X | |||
Cash Flow From Operations | (2.5 M) | |||
Earnings Per Share | (0.01) X | |||
Beta | -224.47 | |||
Market Capitalization | 49.75 K | |||
Total Asset | 3.55 M | |||
Retained Earnings | (25.14 M) | |||
Working Capital | (75 K) | |||
Current Asset | 112 K | |||
Current Liabilities | 187 K | |||
Z Score | -16.4 | |||
Net Asset | 3.55 M |
About OWC Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OWC Pharmaceutical Research's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OWC Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OWC Pharmaceutical Research based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OWC Pharmaceutical Research. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the OWC Pharmaceutical information on this page should be used as a complementary analysis to other OWC Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for OWC Pink Sheet analysis
When running OWC Pharmaceutical's price analysis, check to measure OWC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OWC Pharmaceutical is operating at the current time. Most of OWC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of OWC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OWC Pharmaceutical's price. Additionally, you may evaluate how the addition of OWC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |